| Katie Bates, ARNP | |
|
1201 S Miller St, Wenatchee, WA 98801-3201 | |
| (509) 667-7511 | |
| Not Available |
| Full Name | Katie Bates |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 1201 S Miller St, Wenatchee, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043744501 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | AP60739547 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Washington Hospital | Wenatchee, WA | Hospital |
| Mid Valley Hospital | Omak, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Washington Health Services Association | 4880504596 | 645 |
News Archive
Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.
Researchers based at the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Moorfields Eye Hospital and UCL Institute of Ophthalmology, received funding from Fight for Sight and the Special Trustees of Moorfields Eye Hospital NHS Foundation Trust which has resulted in the design of a new test that can spot the first stages of sight loss in age-related macular degeneration (AMD).
Patients in London are benefiting from ‘quicker, more accurate' surgical procedures following the introduction of a ‘pioneering' and ‘progressive' 3D camera system which improves the hand-eye coordination of surgeons.
At present, bacteria, fungi or viruses can generally only be detected with certainty by way of elaborate laboratory tests or animal experiments. The food and pharmaceutical industries would like to have faster tests to check their products.
› Verified 4 days ago
| Entity Name | Central Washington Health Services Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801937453 PECOS PAC ID: 4880504596 Enrollment ID: O20031106000287 |
News Archive
Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.
Researchers based at the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Moorfields Eye Hospital and UCL Institute of Ophthalmology, received funding from Fight for Sight and the Special Trustees of Moorfields Eye Hospital NHS Foundation Trust which has resulted in the design of a new test that can spot the first stages of sight loss in age-related macular degeneration (AMD).
Patients in London are benefiting from ‘quicker, more accurate' surgical procedures following the introduction of a ‘pioneering' and ‘progressive' 3D camera system which improves the hand-eye coordination of surgeons.
At present, bacteria, fungi or viruses can generally only be detected with certainty by way of elaborate laboratory tests or animal experiments. The food and pharmaceutical industries would like to have faster tests to check their products.
› Verified 4 days ago
| Entity Name | Wenatchee Valley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669719688 PECOS PAC ID: 9537309869 Enrollment ID: O20130716000034 |
News Archive
Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.
Researchers based at the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Moorfields Eye Hospital and UCL Institute of Ophthalmology, received funding from Fight for Sight and the Special Trustees of Moorfields Eye Hospital NHS Foundation Trust which has resulted in the design of a new test that can spot the first stages of sight loss in age-related macular degeneration (AMD).
Patients in London are benefiting from ‘quicker, more accurate' surgical procedures following the introduction of a ‘pioneering' and ‘progressive' 3D camera system which improves the hand-eye coordination of surgeons.
At present, bacteria, fungi or viruses can generally only be detected with certainty by way of elaborate laboratory tests or animal experiments. The food and pharmaceutical industries would like to have faster tests to check their products.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katie Bates, ARNP 1201 S Miller St, Wenatchee, WA 98801-3201 Ph: () - | Katie Bates, ARNP 1201 S Miller St, Wenatchee, WA 98801-3201 Ph: (509) 667-7511 |
News Archive
Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.
Researchers based at the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Moorfields Eye Hospital and UCL Institute of Ophthalmology, received funding from Fight for Sight and the Special Trustees of Moorfields Eye Hospital NHS Foundation Trust which has resulted in the design of a new test that can spot the first stages of sight loss in age-related macular degeneration (AMD).
Patients in London are benefiting from ‘quicker, more accurate' surgical procedures following the introduction of a ‘pioneering' and ‘progressive' 3D camera system which improves the hand-eye coordination of surgeons.
At present, bacteria, fungi or viruses can generally only be detected with certainty by way of elaborate laboratory tests or animal experiments. The food and pharmaceutical industries would like to have faster tests to check their products.
› Verified 4 days ago
Christine A Young, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 933 Red Apple Rd Ste C, Wenatchee, WA 98801 Phone: 509-663-8767 Fax: 509-663-1421 | |
Vivian Lockett, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 600 Orondo Ave, Wenatchee, WA 98801 Phone: 509-662-6000 | |
Michelle Freiberger, ARNP,BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Mrs. Kelli Jean Dilks, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 246 N Mission St, Wenatchee, WA 98801 Phone: 509-662-1955 Fax: 509-662-6695 | |
Miss Tess Astley, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 636 Valley Mall Pkwy Ste 5, Wenatchee, WA 98802 Phone: 509-888-3496 | |
Julia Wolf, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 |